Zimmer Biomet reported $8.51B of revenue over the trailing twelve months, +8.6% on the year before. 11 reported series are charted on this page, each one as filed. Revenue, trailing twelve months: $8.51B (to Q2 2026). Net income: $807M, trailing twelve months to Q2 2026. Free cash flow: $1.52B, trailing twelve months to Q2 2026. Operating margin: 14%, trailing twelve months to Q2 2026.

ZBHZimmer Biomet

Healthcare

$89.12-10% 1Y

$89.12

$79.5852 weeks$103.42

ZBH as reported

Zimmer Biomet reported $8.51B of revenue over the trailing twelve months, +8.6% on the year before. 11 reported series are charted on this page, each one as filed.

$8.51B

Revenue, trailing twelve months · to Q2 2026 · +8.6% against the twelve months before

Net income: $807M
Net income · −2.0% year on year · trailing twelve months to Q2 2026
Free cash flow: $1.52B
Free cash flow · +3.4% year on year · trailing twelve months to Q2 2026
Operating margin: 14%
Operating margin · trailing twelve months to Q2 2026

Details›

Every series Ryufin has for ZBH, trailing twelve months
Series	Latest	Year on year	As of
Revenue	$8.51B	+8.6%	Q2 2026
Net income	$807M	−2.0%	Q2 2026
EPS	$4.12	+0.49%	Q2 2026
Gross margin	70%	n/a	Q2 2026
Operating margin	14%	n/a	Q2 2026
Net margin	9.6%	n/a	Q2 2026
ROE	6.1%	n/a	Q2 2026
ROA	3.3%	n/a	Q2 2026
ROIC	4.8%	n/a	Q2 2026
Free cash flow	$1.52B	+3.4%	Q2 2026
P/E	21.6	n/a	today

Every figure straight from the statements filed with the SEC, no scoring. Per-share figures and share counts are restated for stock splits, so a split never shows up as a collapse. Open a series for its full history.